Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Kenneth J. C. Lim"'
2
Zanubrutinib for the treatment of Waldenström Macroglobulinemia
Autor: Constantine S. Tam, Kenneth J C Lim
Publikováno v: Expert Review of Hematology. 13:1303-1310
Introduction: Waldenstrom Macroglobulinaemia (WM) is a heterogeneous, incurable condition which often relapses after chemoimmunotherapy. Novel therapies such as Bruton tyrosine-kinase (BTK) inhibitors have shown to be efficacious in treating WM but w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c3234e7c66352b0cb7a2a74f562550
https://doi.org/10.1080/17474086.2020.1851184
Zobrazit plný text záznamu
3
Characteristics and outcome of patients with relapsed/refractory Hodgkin lymphoma following front-line escalated BEACOPP-based chemotherapy: a report from the Australasian Lymphoma Alliance
Autor: Ingemar Lagerlöf, Tara Cochrane, Matthew Harwood, Matthew Ku, Georgina Hodges, Constantine S. Tam, Kenneth J C Lim, Xuan Tan, Chan Yoon Cheah
Publikováno v: Leukemia & Lymphoma. 61:3412-3416
The optimal management of the small number of patients who experience early failure of eBEACOPP in Hodgkin lymphoma (HL) is unclear. We identified 12 patients with HL who progressed within 12 months of the front-line therapy between January 2010 and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c3a912d90e93e4e2bc39bc095f926b9
https://doi.org/10.1080/10428194.2020.1811273
Zobrazit plný text záznamu
5
An evaluation of Ibrutinib for the treatment of Waldenstrom macroglobulinaemia
Autor: Kenneth J C Lim, Constantine S. Tam
Publikováno v: Expert opinion on pharmacotherapy. 21(13)
Waldenstrom Macroglobulinaemia (WM) is a heterogenous condition which poses a challenge to manage. Novel therapies such as Ibrutinib have been shown to be efficacious in treating WM. The landscape of Ibrutinib's role in treating WM is everchanging wi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a40d6f5d33cd522703fdff8f342b6da
https://pubmed.ncbi.nlm.nih.gov/32603202
Zobrazit plný text záznamu
7
Real-World Outcomes of Aggressive B-Cell Non-Hodgkin Lymphoma in People Living with HIV (PLWH) Treated in Australia: An Australasian Lymphoma Alliance Study
Autor: William Ph Kermode, Sam Milliken, Tara Cochrane, Maya Latimer, Pietro R Di Ciaccio, Nada Hamad, Briony Shaw, Kenneth J C Lim, Michael Gilbertson, Zhong Goh, Chan Yoon Cheah, Mark N. Polizzotto, Matthew Ku, Evelyn Perry
Publikováno v: Blood. 138:1456-1456
Background Modern antiretroviral therapy (ART) has reduced HIV associated morbidity and mortality, and allowed a similar treatment approach of aggressive lymphomas in PLWH to that of their HIV negative counterparts. Australia is an ethnically diverse
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::19179f771d5b676a96757e7324327d78
https://doi.org/10.1182/blood-2021-144817
Zobrazit plný text záznamu
8
Inferior Outcomes for Multiple Myeloma (MM) Patients (pts) Harbouring t(11;14) and the Promise of Venetoclax, Real-World Australian Retrospective
Autor: Andrew Lim, David Routledge, Nicole Zeglinas, Michelle Ho, Pratheepan Puvanakumar, Matthew Murphy, Sue Morgan, Kenneth J C Lim, James Anton Kuzich, Michael S.Y. Low, Joanna Loh, Dipti Talaulikar, Joanne L. C. Tan, Slavisa Ninkovic, Simon D. Gibbs
Publikováno v: Blood. 138:4752-4752
Introduction/ Background Traditionally, MM harbouring t(11;14) is considered standard risk disease. In the era of novel therapies, however, pts with t(11;14) are reported to have inferior outcomes to other standard risk pts. Evidence of response to t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a6c312f1001a70b9355bc86476d4915e
https://doi.org/10.1182/blood-2021-145508
Zobrazit plný text záznamu
9
Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of 'real-world' experience from Western Australia
Autor: Kenneth J. C. Lim, Gavin Cull, Kate Denning, Michael F. Leahy, David Joske, Andrew P. Hutchison, Matthew Wright, James Anton Kuzich, Portia Smallbone, Dejan Radeski, Duncan Purtill
Publikováno v: Leukemialymphoma. 60(14)
We present an analysis of 98 consecutive patients with peripheral T-cell lymphoma (PTCL) treated over a 10-year period within Western Australia. The most common frontline therapies were CHO(E)P (47%), HyperCVAD (21%), and reduced intensity therapy or
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::424422f4f5e9d9b199f5dda09ed50c95
https://pubmed.ncbi.nlm.nih.gov/31304820
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje